UBT251 Injection Phase II Clinical Study (CKD)

Clinical trial NCT07134335 · RECRUITING

Trial details

NCT number: NCT07134335
Sponsor: The United Bio-Technology (Hengqin) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity &Amp; Overweight Chronic Kidney Disease

Start date: 2025-09-01
Primary completion: 2030-07-11
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.